| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma
|
Sheng, Iris Y.
|
|
|
15 |
2 |
p. 211-220
|
artikel
|
| 2 |
Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study
|
Lou, Yuqing
|
|
|
15 |
2 |
p. 175-184
|
artikel
|
| 3 |
Genomic Alterations and MYD88MUT Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib
|
Jiang, Shiyu
|
|
|
15 |
2 |
p. 221-230
|
artikel
|
| 4 |
Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients
|
Kim, Jinchul
|
|
|
15 |
2 |
p. 203-209
|
artikel
|
| 5 |
Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer
|
Cho, Yong-Hee
|
|
|
15 |
2 |
p. 241-247
|
artikel
|
| 6 |
Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model
|
Ramsey, Haley E.
|
|
|
15 |
2 |
p. 231-240
|
artikel
|
| 7 |
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
|
Ramanathan, Ramesh K.
|
|
|
15 |
2 |
p. 163-174
|
artikel
|
| 8 |
Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice
|
Buchler, Tomas
|
|
|
15 |
2 |
p. 193-201
|
artikel
|
| 9 |
Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond
|
Choi, Jun H.
|
|
|
15 |
2 |
p. 147-162
|
artikel
|
| 10 |
Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study
|
Byeon, Seonggyu
|
|
|
15 |
2 |
p. 185-192
|
artikel
|
Tijdschrift beschrijving